Skip to content

Erlotinib Impurity 33

Erlotinib Impurity 33

Product Description
CAT No.
ALN-E018055
CAS No.
1839513-98-2
Mol. F.
C13H17N3O4
Mol. Wt.
279.3
Stock
Please Inquire
Chemical Name : 2-((4-amino-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethan-1-ol
Smiles : NC1=NC=NC2=CC(OCCOC)=C(OCCO)C=C21
Inchi : InChI=1/C34H43N3O14/c1-4-18-6-5-7-19(12-18)37(32-20-13-22(47-10-8-45-2)23(48-11-9-46-3)14-21(20)35-17-36-32)33-29(43)28(42)31(25(16-39)49-33)51-34-30(44)27(41)26(40)24(15-38)50-34/h1,5-7,12-14,17,24-31,33-34,38-44H,8-11,15-16H2,2-3H3

Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: A dose-escalation study

Chris Twelvesa, Joseu00b4 M. Trigob , Rob Jonesc , Flavio De Rosad , Ashok Rakhite , Scott Fettnere , Tonya Wrightc , Joseu00b4 BaselganEuropean journal of cancer 44 (2008) 419 u2013 426

Development and validation of a stability indicating HPLC method for the quantification of impurities in Erlotinib hydrochloride dosage forms

BabuC1, Narasimha\xa0 RaoK.L1,\xa0 DevannaN1, Suresh Reddy\xa0 K.V.N – Solubility Measurement and Correlation of Two Erlotinib Hydrochloride Polymorphs in Alcohols and Ketones from 273.15 to 323.15 K

Jinghuan Zhai, Junrui Zhao, Zhenzhen Chen, Changwei Xiao, Xijian Liu, Lijuan Zhang, and Jie Lu

J. Chem. Eng. Data 2017, 62, 1, 516–524 – Separation and Determination of Process-Related Impurities of Erlotinib Using Reverse-Phase HPLC with a Photo-Diode Array Detector

Request For Quotation